Urokinase-type Plasminogen Activator Receptor and Gastroesophageal Cancer
Clinical trial NCT04669951 · COMPLETED
Trial details
- NCT number
- NCT04669951
- Sponsor
- Michael Patrick Achiam
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-18
- Primary completion
- 2020-11-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.